You are here

ALBA THERAPEUTICS CORPORATION

Company Information
Address
2400 BOSTON STREET SUITE 334
BALTIMORE, MD 21224
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

    Amount: $265,312.00

    DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeabil ...

    STTRPhase I2006Department of Health and Human Services National Institutes of Health
  2. Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

    Amount: $265,312.00

    DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeabil ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government